Cargando…
Leflunomide an immunomodulator with antineoplastic and antiviral potentials but drug-induced liver injury: A comprehensive review
Leflunomide (LF) represents the prototype member of dihydroorotate dehydrogenase (DHODH) enzyme inhibitors. DHODH is a mitochondrial inner membrane enzyme responsible for catalytic conversion of dihydroorotate into orotate, a rate-limiting step in the de novo synthesis of the pyrimidine nucleotides....
Autores principales: | Alamri, Raghad D., Elmeligy, Mazen A., Albalawi, Ghadeer A., Alquayr, Sarah M., Alsubhi, Samaher S., El-Ghaiesh, Sabah H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7869628/ https://www.ncbi.nlm.nih.gov/pubmed/33571819 http://dx.doi.org/10.1016/j.intimp.2021.107398 |
Ejemplares similares
-
Side effects of antineoplastic and immunomodulating medications reported by European consumers
por: Aagaard, Lise, et al.
Publicado: (2013) -
Antiviral and Immunomodulation Effects of Artemisia
por: Kshirsagar, Suhas G., et al.
Publicado: (2021) -
Combining immunomodulators and antivirals for COVID-19
por: Chen, Luke Y C, et al.
Publicado: (2021) -
Leflunomide-Induced Hidradenitis Suppurativa
por: Machan, Achraf, et al.
Publicado: (2020) -
Combining Antivirals and Immunomodulators to Fight COVID-19
por: Feuillet, Vincent, et al.
Publicado: (2021)